Bernard Oppong v. United States

CourtCourt of Appeals for the Sixth Circuit
DecidedFebruary 28, 2025
Docket24-3246
StatusUnpublished

This text of Bernard Oppong v. United States (Bernard Oppong v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bernard Oppong v. United States, (6th Cir. 2025).

Opinion

NOT RECOMMENDED FOR PUBLICATION File Name: 25a0117n.06

No. 24-3246

UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT FILED Feb 28, 2025 KELLY L. STEPHENS, Clerk ) BERNARD OPPONG, ) Petitioner-Appellant, ) ON APPEAL FROM THE ) UNITED STATES DISTRICT v. ) COURT FOR THE SOUTHERN ) DISTRICT OF OHIO UNITED STATES OF AMERICA, ) Respondent-Appellee. ) OPINION ) )

Before: CLAY, WHITE, and DAVIS, Circuit Judges.

CLAY, Circuit Judge. Petitioner Bernard Oppong appeals the district court’s judgment

denying his motion to vacate sentence pursuant to 28 U.S.C. § 2255. The district court granted a

certificate of appealability on the sole question of whether the government presented sufficient

evidence of subjective intent to support Oppong’s drug-related convictions. For the reasons set

forth below, we AFFIRM the district court’s judgment.

I. BACKGROUND

A. Factual Background

Petitioner Bernard Oppong worked as a medical doctor at Health and Wellness Medical

Center, LLC (“HWMC”), an opioid treatment facility owned by pharmacists Darrell Bryant and

Gifty Kusi, who also operated Health and Wellness Pharmacy, LLC (“HWP”). During Dr.

Oppong’s time working for Bryant and Kusi, he became involved in two primary types of illegal No. 24-3246, Oppong v. United States

conduct by HWMC and HWP. One concerned the sale of compounded creams, and the other

concerned the unauthorized prescribing of Suboxone, a Schedule III controlled substance.

1. Compound Cream Prescriptions

Pharmacists Bryant and Kusi worked to manufacture and sell compound creams out of the

HWP business with the help of HWP physicians and employees. HWP physicians, including Dr.

Oppong, prescribed the creams to some patients without a physical examination. The creams were

then shipped directly to patients, allowing for multiple refills. Recipients of the creams included

patients of Clinic 5, an opioid treatment center, as well as shoppers of Sav-a-Lot grocery store,

where HWP operated a small location resembling “a little storeroom” that was almost “like a

closet.” See Trial Tr., R. 37, Page ID #479–81. Inside the Save-a-Lot store, non-physician

employees of HWP would confront grocery shoppers and ask them questions about their health,

particularly with respect to any skin or pain problems, with the goal of selling the creams. No

physical examinations were performed on these shoppers. Later, pharmacist Bryant would pick

up the questionnaires completed by shoppers.

In addition to the Clinic 5 patients and Sav-a-Lot shoppers, HWP solicited other purchasers

for the creams by sending a non-physician employee to canvass neighborhoods door-to-door and

conduct mobile visits by van. One such employee, Jamie Snyder, resigned from her role as a nurse

practitioner after being asked to sign stacks of cream prescriptions prepared by pharmacist Kusi.

Meanwhile, Dr. Oppong and another physician, Dr. Rivera, acquiesced to signing the prescriptions.

Both doctors prescribed compound creams for patients they had not met. Dr. Oppong prescribed

no less than $589,000 worth of creams compounded by HWP.

Most of these cream prescriptions went to participants in the Medicaid-based health plan,

CareSource. For certain medications, such as compounded creams, CareSource used a prior

-2- No. 24-3246, Oppong v. United States

authorization system to certify proper use. At the time of these events, the threshold amount

requiring prior authorization at CareSource was $300; however, since most of HWP’s cream

prescriptions were billed for less than that amount, they went unchallenged. As a result of Dr.

Oppong’s signing prescriptions for patients he had not examined, claims were submitted to

Medicaid representing that the creams were medically necessary. Several patients received the

compound creams prescribed by Dr. Oppong without ever meeting him. Because of HWP’s

unusually high volume of cream prescriptions, CareSource eventually contacted the Ohio Board

of Pharmacy regarding their legitimacy. Dr. Rivera, who had initially prescribed the creams

alongside Dr. Oppong, became concerned about signing the prescriptions for patients without first

examining them, and contacted the Board for advice. In July 2015, search warrants were executed

at multiple HWP and HWMC locations by the Board of Pharmacy, Medicaid Fraud Control Unit,

Attorney General’s Office, the DEA, the FBI, and the Dublin Police.

2. Suboxone Prescriptions

In February 2015, HWMC’s decision to begin accepting insurance and Medicaid caused

their patient population to increase significantly. The clinic atmosphere grew crowded and

disorganized, turning into “a madhouse.” Trial Tr., R. 38, Page ID #881. Patients were required

to participate in counseling to get their prescriptions, but these counseling sessions were

overcrowded and only loosely enforced. See Trial Tr., R. 39, Page ID #960 (noting that one patient

described counseling as “a joke,” with a counselor saying, “if you want to take a nap, you can take

a nap”). Accompanying this disorder within the clinic, owners and pharmacists Bryant and Kusi

instructed Dr. Oppong to pre-sign prescriptions of Suboxone.

Suboxone is a Schedule III controlled substance used to treat opioid-use disorder. It has a

street value and is often sought by individuals trying to self-medicate or sustain themselves until

-3- No. 24-3246, Oppong v. United States

they can obtain a more potent drug to “get high.” Trial Tr., R. 38, Page ID #763. Accordingly,

physicians are bound to certain guidelines when prescribing the drug to avoid the risk of diversion.

Dr. Oppong was registered with state and federal authorities to prescribe controlled substances and

had a special registration, known as a data waiver, which permitted him to prescribe Suboxone to

a small number of patients each month. The applicable regulations required that the prescriptions

be dated and signed on the date issued. Despite this, Dr. Oppong and other HWMC physicians

with data waivers pre-signed the prescriptions of Suboxone without dating them or completing the

dosing information. These prescriptions would be placed in patient’s charts and distributed at

various times when the prescribing physician was not present. Any incomplete information on the

prescriptions, such as the name, date, dispense number, or date of birth, would be completed by a

non-physician employee at check-out.

This practice of placing pre-signed prescriptions in patient charts allowed HWMC to

process patients more quickly and bill for additional services. On some occasions, the patients

would be seen by another doctor on the date of the prescription being signed, but other times they

did not see any doctor and “just got the prescription regardless.” Trial Tr., R. 39, Page ID #907.

Dr. Oppong also signed progress notes for patients who had only been examined by Bryant, a non-

physician. On one occasion, Dr. Oppong “had somewhere to be,” so he “signed a bunch of the

patient’s charts and then a bunch of blank prescriptions so that way all the patients had

prescriptions for the day.” Trial Tr., R. 39, Page ID #919; see also R. 39 at Page ID #972 (observing

that the medical clinic “had a stack of prescriptions that sometimes were already signed and filled

out”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jackson v. Virginia
443 U.S. 307 (Supreme Court, 1979)
Cheek v. United States
498 U.S. 192 (Supreme Court, 1991)
Bousley v. United States
523 U.S. 614 (Supreme Court, 1998)
United States v. Hubert R. Ferguson
918 F.2d 627 (Sixth Circuit, 1990)
John W. Gall v. United States
21 F.3d 107 (Sixth Circuit, 1994)
Michael Jeffrey Johnson v. Ralph Coyle, Warden
200 F.3d 987 (Sixth Circuit, 2000)
Elda San Juanita Regalado v. United States
334 F.3d 520 (Sixth Circuit, 2003)
Darryl M. Durr v. Betty Mitchell, Warden
487 F.3d 423 (Sixth Circuit, 2007)
Brown v. Konteh
567 F.3d 191 (Sixth Circuit, 2009)
Donavon Huff v. United States
734 F.3d 600 (Sixth Circuit, 2013)
United States v. Paul Volkman
797 F.3d 377 (Sixth Circuit, 2015)
United States v. Ruth Robinson
813 F.3d 251 (Sixth Circuit, 2016)
United States v. Lynn Michael LaVictor
848 F.3d 428 (Sixth Circuit, 2017)
Xiulu Ruan v. United States
597 U.S. 450 (Supreme Court, 2022)
United States v. Roger Anderson
67 F.4th 755 (Sixth Circuit, 2023)
United States v. William Bauer
82 F.4th 522 (Sixth Circuit, 2023)
United States v. John Stanton, M.D.
103 F.4th 1204 (Sixth Circuit, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
Bernard Oppong v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bernard-oppong-v-united-states-ca6-2025.